BDL
Flanigan's Enterprises, Inc.
BDL has the edge over LCID overall, supported by lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
BDL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
BDL's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
BDL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $26.57 | -54% |
| Fair | 13x | $45.98 | -20% |
| Current | 16x | $57.38 | — |
| Expensive | 18x | $64.49 | +12% |
Historical ranges are pointers, not guarantees.
BDL's PE is in its expensive range at 16x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
BDL Forward outlook
There aren't enough analyst estimates for BDL to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
BDL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.57 | +53% |
| Q1 2026 | $3.21 | +47% |
| Q4 2025 | $3.11 | +76% |
| Q3 2025 | $2.71 | +51% |
| Q2 2025 | $2.33 | +43% |
| Q1 2025 | $2.18 | +15% |
| Q4 2024 | $1.77 | +49% |
| Q3 2024 | $1.80 | +22% |
BDL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
BDL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $56.2M | +7.7% |
| Q1 2026 | $56.5M | +5.4% |
| Q4 2025 | $52.6M | +4.6% |
| Q3 2025 | $50M | +8.7% |
| Q2 2025 | $52.2M | +6.2% |
| Q1 2025 | $53.6M | +12% |
| Q4 2024 | $50.3M | +11% |
| Q3 2024 | $46M | +6.1% |
BDL's revenue has grown year over year for 23 quarters in a row: $56M last quarter, up 7.7% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 7.1% | +1.4 points |
| Q1 2026 | 7.4% | +0.6 points |
| Q4 2025 | 3.2% | +1.5 points |
| Q3 2025 | 3.3% | +1.9 points |
| Q2 2025 | 5.7% | +1 points |
| Q1 2025 | 6.8% | +1.2 points |
| Q4 2024 | 1.7% | -0.1 points |
| Q3 2024 | 1.4% | +0.4 points |
BDL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over BDL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
BDL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$3.5M | -$1.8M |
| Q1 2026 | $1.3M | +$4.2M |
| Q4 2025 | $4.5M | -36% |
| Q3 2025 | $2.4M | +546% |
| Q2 2025 | -$1.8M | -180% |
| Q1 2025 | -$3M | -$780K |
| Q4 2024 | $7M | +150% |
| Q3 2024 | $376K | -94% |
BDL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
BDL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -- |
| 1 year | 0% | -- |
| 3 years | 0% | -- |
| 5 years | 0% | -- |
| Available history | 0% | -- |
BDL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
BDL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -0.2x | Net Cash |
| Q4 2025 | 388.0x | High |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | 0.2x | Very low |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | -0.7x | Net Cash |
| Q3 2024 | 0.1x | Very low |
BDL's net debt is less than a year of its operating earnings (EBITDA).
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
BDL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.5 | Overbought |
| Stochastic | 73.8 | Neutral |
BDL's weekly RSI is 71 (overbought) and its Stochastic is 74 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
BDL PE vs Consumer Cyclical Sector
| Metric | BDL | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 79 | 47 | 32 pts above |
BDL is trading at 16x earnings, a 11% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
BDL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $51.3 | 12% above |
| 20 week MA | $47.3 | 21% above |
| 50 week MA | $38.5 | 49% above |
| 100 week MA | $33.3 | 72% above |
| 200 week MA | $30.4 | 89% above |
BDL has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
BDL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $22.6 | $19.9 | -12% |
| 2021 | $19.9 | $30.5 | +54% |
| 2022 | $30.5 | $26.5 | -13% |
| 2023 | $26.5 | $25.7 | -2.9% |
| 2024 | $25.7 | $25.1 | -2.3% |
| 2025 | $25.1 | $29.6 | +18% |
| 2026 YTD | $29.6 | $57.4 | +94% |
BDL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.